OTC:AVCNF Avicanna (AVCNF) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free AVCNF Stock Alerts $0.25 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.25▼$0.2550-Day Range$0.23▼$0.4152-Week Range$0.18▼$0.53Volume7,500 shsAverage Volume10,099 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Avicanna alerts: Email Address Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... About Avicanna Stock (OTC:AVCNF)Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.Read More AVCNF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVCNF Stock News HeadlinesApril 18, 2024 | globenewswire.comAvicanna Announces Closing of Non-brokered Private PlacementApril 10, 2024 | globenewswire.comAvicanna Announces Completion of Topical Gel Observational Real-World Evidence StudyMay 4, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...April 2, 2024 | msn.comCannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoYApril 2, 2024 | globenewswire.comAvicanna Reports Full Year 2023 Audited Financial ResultsMarch 27, 2024 | globenewswire.comAvicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary FormulationMarch 26, 2024 | finance.yahoo.comAvicanna To Hold Full Year 2023 Earnings Conference CallMarch 26, 2024 | globenewswire.comAvicanna To Hold Full Year 2023 Earnings Conference CallMay 4, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...February 29, 2024 | globenewswire.comAvicanna Hosts Symposium on Cannabinoid-based MedicineFebruary 15, 2024 | finance.yahoo.comAvicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical CompanyFebruary 15, 2024 | finance.yahoo.comAvicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical CompanyFebruary 15, 2024 | globenewswire.comAvicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical CompanyFebruary 13, 2024 | markets.businessinsider.comAvicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™February 5, 2024 | finanznachrichten.deAvicanna Inc.: Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical CompanyFebruary 5, 2024 | msn.comAvicanna signs supply and licensing agreement with pharmaceutical companyFebruary 5, 2024 | msn.comCBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply DealFebruary 5, 2024 | finance.yahoo.comAvicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical CompanyJanuary 30, 2024 | finanznachrichten.deAvicanna Inc.: Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in BrazilJanuary 3, 2024 | investing.comAvicanna raises CAD888,128 through private placement at CAD0.35 per unitJanuary 3, 2024 | theglobeandmail.comClosing Bell: Avicanna Inc flat on Tuesday (AVCN)December 5, 2023 | msn.comCBD-Focused Avicanna Announces Funding Boost For Research And DevelopmentNovember 21, 2023 | finance.yahoo.comAvicanna To Hold Third Quarter 2023 Earnings Conference CallNovember 21, 2023 | finance.yahoo.comAvicanna Announces Appointment of Paul Fornazzari to Board of DirectorsNovember 21, 2023 | finance.yahoo.comAvicanna Reports Q3 2023 ResultsMay 16, 2023 | finanznachrichten.deAvicanna Inc.: Avicanna Reports Q1 2023 Financial StatementMay 16, 2023 | proactiveinvestors.comAvicanna increases 1Q revenue, drives down G&A costs as it expands medical cannabis sales in CanadaSee More Headlines Receive AVCNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avicanna and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/04/2024Next Earnings (Estimated)5/13/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTC:AVCNF CUSIPN/A CIKN/A Webwww.avicanna.com Phone1.647.243.5283FaxN/AEmployees87Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Aras Azadian B.EconMba, Co-Founder, CEO & DirectorMr. Phillip Cardella C.A.CPA, Chief Financial OfficerDr. Frantz Le DevedecExecutive Vice President of Research & DevelopmentMr. Stephen KimChief Legal Officer & General Counsel of Avicanna USA Inc.Mr. Arash Moghani MBAExecutive Vice President of Operations & TechnologyMs. Ingrid DiazVP, Assistant General Counsel & Corporate Compliance OfficerMs. Ivana MaricExecutive Vice President of MarketingMr. Enric PujolVice President of PeopleDr. Carlos Enrique Maldonado MueteSVP of Clinical DevelopmentDr. Karolina UrbanExecutive Vice President of Scientific & Medical AffairsMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors AVCNF Stock Analysis - Frequently Asked Questions How have AVCNF shares performed in 2024? Avicanna's stock was trading at $0.2683 at the beginning of 2024. Since then, AVCNF stock has decreased by 6.6% and is now trading at $0.2506. View the best growth stocks for 2024 here. When is Avicanna's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our AVCNF earnings forecast. How do I buy shares of Avicanna? Shares of AVCNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:AVCNF) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avicanna Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.